Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea · Delayed Price · Currency is KRW 50,400
-1,100 (-2.14%)
Apr 29, 2026, 9:40 AM KST
81.29% (1Y)
| Market Cap | 2.62T +92.9% |
| Revenue (ttm) | 155.18B +11.7% |
| Net Income | -5.56B |
| EPS | -109.48 |
| Shares Out | 50.78M |
| PE Ratio | n/a |
| Forward PE | 1,376.43 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 37,603 |
| Average Volume | 408,329 |
| Open | 51,100 |
| Previous Close | 51,500 |
| Day's Range | 50,300 - 51,800 |
| 52-Week Range | 24,000 - 66,600 |
| Beta | 0.91 |
| RSI | 51.13 |
| Earnings Date | May 13, 2026 |